Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intracoronary Tirofiban for No-Reflow in STEMI
NCT06966674Recruiting
- Sponsor
- Kafrelsheikh University
- Start
- May 2025
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of tirofiban in ST-segment elevation myocardial infarction (STEMI) (2 arms), sponsored by Kafrelsheikh University. Primary endpoint: Blood stream at 15 minutes. Started May 2025; status: recruiting.
02
Drugs
tirofiban
03
Conditions
ST-segment elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT06966674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06966674.